Surrey Clinical Research Centre, University of Surrey
Guildford, GU2 7XP, United Kingdom
NCT Number: NCT01447641
The purpose of this study is to assess both the sleep and circadian (24-hourly biological rhythms) physiology of people with cluster headache. For sufferers with the episodic form of the disorder this will involve observation at two separate time points, once when experiencing attacks (in-bout) and once when attack free (out-of-bout).
The study will include measurement of basic rest-activity patterns, sleep timing and timing of individual attacks, as well as a more detailed study recording sleep and circadian rhythms under clinical conditions over consecutive nights.
Studying the differences in these processes in single individuals when they are both experiencing and free from attacks might provide insight into the brain mechanisms involved in triggering the bouts of attacks and individual attacks themselves. An improved understanding of this area may help design improved treatment options in future.
Looking for future studies?
Notify Me16 year–75 year
All sexes
Observational
Guildford, GU2 7XP, United Kingdom
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Overnight physiological recording of sleep
Wristwatch activity to measure basic rest activity cycle and sleep efficiency
Time frame: 36 hours
University of Surrey
Other
Characterisation of Sleep and Circadian Physiology in Individuals With Cluster Headache
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05023460
Brain Diseases, Central Nervous System Diseases
Aarhus N, Denmark
View Trial DetailsNCT04970355
Brain Disease, Brain Diseases
München, Bavaria, Germany
View Trial DetailsNCT04930887
Brain Diseases, Central Nervous System Diseases
Stanford, California, United States
View Trial DetailsNCT03511846
Brain Diseases, Central Nervous System Diseases
Houston, Texas, United States
View Trial Details